Globus Medical (NYSE:GMED) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Globus Medical, Inc. (NYSE:GMED). In a filing disclosed on September 10th, the Representative disclosed that they had bought between $15,001 and $50,000 in Globus Medical stock on August 19th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 8/28/2026.
• Purchased $15,001 – $50,000 in shares of Quanta Services (NYSE:PWR) on 8/27/2026.
• Purchased $15,001 – $50,000 in shares of Eaton (NYSE:ETN) on 8/27/2026.
• Sold $15,001 – $50,000 in shares of NIKE (NYSE:NKE) on 8/27/2026.
• Sold $1,001 – $15,000 in shares of Phreesia (NYSE:PHR) on 8/26/2026.
• Purchased $1,001 – $15,000 in shares of Wheaton Precious Metals (NYSE:WPM) on 8/26/2026.
• Purchased $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 8/26/2026.
• Purchased $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 8/26/2026.
• Sold $15,001 – $50,000 in shares of Lamar Advertising (NASDAQ:LAMR) on 8/25/2026.
• Sold $1,001 – $15,000 in shares of Phreesia (NYSE:PHR) on 8/25/2026.

Globus Medical Stock Performance

Shares of NYSE GMED traded up $0.65 during mid-day trading on Friday, reaching $74.21. The company’s stock had a trading volume of 1,486,355 shares, compared to its average volume of 1,066,102. The stock has a 50-day moving average of $80.40 and a two-hundred day moving average of $83.82. The stock has a market capitalization of $9.96 billion, a P/E ratio of 18.98, a P/E/G ratio of 1.18 and a beta of 0.95. Globus Medical, Inc. has a 1-year low of $54.15 and a 1-year high of $101.40.

Globus Medical (NYSE:GMED) last posted its quarterly earnings results on Thursday, August 6th. The medical device company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.24. Globus Medical had a net margin of 17.02% and a return on equity of 14.57%. The firm had revenue of $789.61 million for the quarter, compared to analyst estimates of $782.88 million. During the same period in the previous year, the business posted $0.86 earnings per share. Globus Medical’s quarterly revenue was up 5.9% on a year-over-year basis. Globus Medical has set its FY 2026 guidance at 4.950-5.050 EPS. Analysts predict that Globus Medical, Inc. will post 4.99 EPS for the current fiscal year.

Insider Activity at Globus Medical

In related news, Director Stephen Zarrilli sold 25,000 shares of Globus Medical stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $87.04, for a total value of $2,176,000.00. Following the completion of the transaction, the director owned 25,000 shares in the company, valued at approximately $2,176,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 18.38% of the company’s stock.

Institutional Investors Weigh In On Globus Medical

A number of institutional investors have recently modified their holdings of the company. California State Teachers Retirement System lifted its stake in Globus Medical by 7,827.7% during the 2nd quarter. California State Teachers Retirement System now owns 10,326,607 shares of the medical device company’s stock worth $815,905,000 after acquiring an additional 10,196,347 shares in the last quarter. Janus Henderson Group PLC grew its position in Globus Medical by 4.5% in the 1st quarter. Janus Henderson Group PLC now owns 7,623,095 shares of the medical device company’s stock valued at $656,831,000 after acquiring an additional 328,217 shares in the last quarter. Invesco Ltd. increased its stake in Globus Medical by 1,235.2% during the fourth quarter. Invesco Ltd. now owns 3,886,405 shares of the medical device company’s stock worth $339,322,000 after purchasing an additional 3,595,339 shares during the period. Bank of Montreal Can increased its stake in Globus Medical by 15,317.1% during the fourth quarter. Bank of Montreal Can now owns 3,373,260 shares of the medical device company’s stock worth $294,519,000 after purchasing an additional 3,351,380 shares during the period. Finally, Sculptor Capital LP lifted its position in shares of Globus Medical by 1.9% during the first quarter. Sculptor Capital LP now owns 3,058,000 shares of the medical device company’s stock worth $263,477,000 after purchasing an additional 58,000 shares in the last quarter. 95.16% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on GMED shares. UBS Group assumed coverage on Globus Medical in a report on Tuesday, July 28th. They issued a “neutral” rating and a $82.00 price target for the company. BMO Capital Markets started coverage on Globus Medical in a report on Wednesday, July 8th. They issued an “outperform” rating and a $94.00 target price for the company. Royal Bank Of Canada reduced their price target on Globus Medical from $120.00 to $115.00 and set an “outperform” rating on the stock in a report on Monday, July 13th. Wells Fargo & Company reduced their price target on shares of Globus Medical from $103.00 to $99.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. Finally, Zacks Research upgraded Globus Medical from a “hold” rating to a “strong-buy” rating in a report on Monday, August 10th. Three analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Globus Medical presently has a consensus rating of “Moderate Buy” and an average target price of $101.77.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Globus Medical

Globus Medical, Inc (NYSE: GMED) is a medical device company that develops, manufactures and markets musculoskeletal solutions for surgeons, hospitals and patients. Its primary focus is spinal surgery, supported by a portfolio of implants, instruments and enabling technologies designed to assist with procedures involving the cervical, thoracic and lumbar spine.

The company’s products include spinal fusion systems, interbody devices, deformity correction systems, biologics and surgical instruments.